Recruiting IgA Nephropathy Studies in Chubbuck
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
The purpose of this study is to evaluate the long-term safety and tolerability, of open label iptacopan in primary IgA nephropathy participants who have completed either the CLNP023X2203 or CLNP023A23...
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
A study to investigate the impact of iptacopan treatment on the underlying immunopathology in patients with IgAN by assessing changes in key clinical and molecular markers from baseline to 9 months. T...
About IgA Nephropathy Clinical Trials in Chubbuck
IgA nephropathy is the most common form of glomerulonephritis worldwide, caused by deposits of immunoglobulin A in the kidneys. It can lead to kidney inflammation and progressive kidney damage. Treatment includes blood pressure management, immunosuppression, and newer targeted therapies.
There are currently 2 iga nephropathy clinical trials recruiting participants in Chubbuck, IDAHO. These studies are seeking a combined 560 participants. Research is being sponsored by Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
IgA Nephropathy Clinical Trials in Chubbuck — FAQ
Are there iga nephropathy clinical trials in Chubbuck?
Yes, there are 2 iga nephropathy clinical trials currently recruiting in Chubbuck, IDAHO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chubbuck?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chubbuck research site will contact you about next steps.
Are clinical trials in Chubbuck free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chubbuck studies also compensate for your time and travel.
What iga nephropathy treatments are being tested?
The 2 active trials in Chubbuck are testing new therapies including novel drugs, biologics, and treatment approaches for iga nephropathy.
Data updated March 2, 2026 from ClinicalTrials.gov